Apposite Capital is named Private Equity Investor of the Year 2023
We’re delighted that healthcare specialist investor Apposite Capital has been awarded Private Equity Investor of the Year 2023 at the HealthInvestor Awards 2023.
The HealthInvestor Awards celebrate outstanding achievements in the healthcare industry, recognising initiative, innovation and growth amid a backdrop of recent political, environmental and economic challenges.
The category, which saw six finalists competing for the title of Private Equity Investor of the Year, highlighted those companies that have been involved in significant and successful deals in the healthcare sector over the last 12 months.
HCML was acquired by Apposite Capital in November 2021 and has been instrumental in supporting HCML’s growth across its core service areas of specialist case management and treatment delivery, and its expansion into the corporate healthcare market. This includes HCML’s acquisition of healthcare rm, the employee health risk management specialists, in August 2022.
Apposite Capital’s success demonstrates they are leading the way in developing healthcare businesses that are having a significant, positive impact and achieving the best outcomes for people’s health.
Sam Gray, Managing Partner of Apposite Capital said: “In the current economic climate, Apposite has demonstrated its belief in our portfolio companies and management teams, and backed them to achieve significant growth through M&A. The need to invest in businesses that can deliver better healthcare for more people has never been stronger and we look forward to continuing to invest in high growth, high impact opportunities in the sector.”